PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,961,000 | +38.1% | 1,963,062 | +1.2% | 0.00% | +50.0% |
| Q3 2016 | $12,284,000 | +63.8% | 1,940,553 | +9.2% | 0.00% | +100.0% |
| Q2 2016 | $7,499,000 | -4.1% | 1,776,958 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $7,823,000 | -28.6% | 1,794,275 | +0.4% | 0.00% | -50.0% |
| Q4 2015 | $10,951,000 | +5.0% | 1,786,422 | -2.0% | 0.00% | 0.0% |
| Q3 2015 | $10,431,000 | -31.2% | 1,823,589 | -10.3% | 0.00% | 0.0% |
| Q2 2015 | $15,166,000 | +21.9% | 2,033,025 | -2.3% | 0.00% | 0.0% |
| Q1 2015 | $12,442,000 | -20.6% | 2,080,542 | +0.4% | 0.00% | -33.3% |
| Q4 2014 | $15,669,000 | +29.2% | 2,072,661 | -11.3% | 0.00% | +50.0% |
| Q3 2014 | $12,132,000 | +17.3% | 2,337,661 | -2.6% | 0.00% | 0.0% |
| Q2 2014 | $10,345,000 | +6.9% | 2,400,148 | +1.5% | 0.00% | 0.0% |
| Q1 2014 | $9,674,000 | -5.5% | 2,365,364 | +23.2% | 0.00% | 0.0% |
| Q4 2013 | $10,236,000 | +12.9% | 1,920,491 | +6.4% | 0.00% | 0.0% |
| Q3 2013 | $9,064,000 | +36.1% | 1,805,568 | +20.9% | 0.00% | +100.0% |
| Q2 2013 | $6,659,000 | – | 1,493,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |